The prospective multi-centre BIO-LivIQ trial will enrol 325 patients across 60 sites worldwide.

The placement device for the LivIQ leadless pacemaker. [Image courtesy of Biotronik] Biotronik today announced the initiation ...

Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging ...

First MR Conditional Pacemaker Portfolio in the US with Single- and Dual-Chamber Pacemakers LAKE OSWEGO, Oregon,—BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today ...